Biotricity Inc. (NASDAQ:BTCY)

Biotricity is a medical technology company committed to improving healthcare by developing solutions that aid chronic disease prevention and management. Biotricity’s premier product is Bioflux, an ECG monitoring system that will be prescribed by physicians to diagnose and remotely monitor cardiac patients. Biotricity is expanding medical-grade monitoring into the consumer market via its Biolife solution, which empowers users to self-manage chronic conditions. Biolife helps users make lifestyle changes by combining medically relevant ECG data with social media interactivity and a lifestyle log. Biotricity’s R&D continues to focus on the preventative healthcare market, with a vision of putting health management into the hands of the individual. The company aims to support the self-management of critical and chronic conditions with the use of innovative solutions to ease the growing burden on the healthcare system. Biotricity's stock is trading on the OTC Venture Marketplace (OTC QB) under the ticker, “BTCY”.